The platelet-rich plasma and mesenchymal stem cell milieu: A review of therapeutic effects on bone healing
| Autor: | Chelsea S. Bahney, John D. Kisiday, Nicole Ehrhart, Laurie R. Goodrich, Bethany E. Liebig |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Bone Regeneration
Long bone Bone healing Mesenchymal Stem Cell Transplantation Article 03 medical and health sciences 0302 clinical medicine Medicine Animals Humans Orthopedics and Sports Medicine Bone regeneration 030203 arthritis & rheumatology 030222 orthopedics business.industry Platelet-Rich Plasma Regeneration (biology) Mesenchymal stem cell Mesenchymal Stem Cells medicine.anatomical_structure Orthopedics Platelet-rich plasma Cancer research Bone marrow business Wound healing |
| Zdroj: | J Orthop Res |
| ISSN: | 1554-527X |
| Popis: | Platelet-rich plasma is autologous plasma that contains concentrated platelets compared to whole blood. It is relatively inexpensive to produce, can be easily isolated from whole blood, and can be administered while the patient is in the operating room. Further, because platelet-rich plasma is an autologous therapy, there is minimal risk for adverse reactions to the patient. Platelet-rich plasma has been used to promote bone regeneration due to its abundance of concentrated growth factors that are essential to wound healing. In this review, we summarize the methods for producing platelet-rich plasma and the history of its use in bone regeneration. We also summarize the growth factor profiles derived from platelet-rich plasma, with emphasis on those factors that play a direct role in promoting bone repair within the local fracture environment. In addition, we discuss the potential advantages of combining platelet-rich plasma with mesenchymal stem cells, a multipotent cell type often obtained from bone marrow or fat, to improve craniofacial and long bone regeneration. We detail what is currently known about how platelet-rich plasma influences mesenchymal stem cells in vitro, and then highlight the clinical outcomes of administering platelet-rich plasma and mesenchymal stem cells as a combination therapy to promote bone regeneration in vivo. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text